However, disproportionality analyses showed that GLP-1RA is associated with thyroid neoplasms benign and malignant, pancreatic neoplasms malignant, and ICN&AN cases at the HLT level
Furthermore, a prespecified subgroup analysis of HF individuals from the SELECT trial evaluating the effects of semaglutide on cardiovascular outcomes in people with overweight or obesity, which included 2,273 HFpEF and 1,347 HFrEF patients, showed that the therapy was associated with a reduction in the HF composite outcome (cardiovascular death or HF hospitalisation/emergency visit) across LVEF, suggesting that GLP-1 RAs may improve outcomes at least in obese HF patients regardless of diabetes status
It is available online and through free iPhone and Android apps
Presented for research literature review only Abdullayev N et al
Scheduling your injection on the same day each weekwhether Sunday evening or Wednesday morningcreates a predictable rhythm that helps your body adapt and your brain can anticipate when suppression will be strongest